Fund HoldingsPivotal bioVenture Partners Investment Advisor LLC

Total Portfolio Value
$307.79M
Total Bought
$52.51M
Total Sold
$35.56M
Net Transaction
+$16.95M
Filing Period:
Securities
SharesValue ($K)
Q1 2026
Q2 2026
Change
Q1 2026
Q2 2026
Weight (%)
Change
AVALYN PHARMACEUTICALS INC0966,792+966,792031,82710.34%+31,827
TREVI THERAPEUTICS INC(TRVI)1,553,7261,742,672+188,94618,53632,50110.56%+13,965
MAPLIGHT THERAPEUTICS INC(MPLT)611,447611,446-112,43121,9147.12%+9,484
BIOAGE LABS INC(BIOA)653,374653,374011,42816,0145.20%+4,587
AVALO THERAPEUTICS INC(AVTX)295,933434,033+138,1004,4188,0212.61%+3,603
VAXCYTE INC(PCVX)1,372,4251,425,470+53,04579,75282,86326.92%+3,111
RALLYBIO CORP(RLYB)300,579300,57902,6964,8091.56%+2,113
ARCUTIS BIOTHERAPEUTICS INC(ARQT)1,355,8921,265,283-90,60931,94533,17610.78%+1,231
ZENAS BIOPHARMA INC(ZBIO)591,991490,766-101,22511,57312,4564.05%+882
RECURSION PHARMACEUTICALS IN(RXRX)595,518595,51801,8282,1860.71%+357
BOLT BIOTHERAPEUTICS INC42,5810-42,5811720-172
IMMUNOME INC(IMNM)732,512732,512016,02015,5225.04%-498
EVOMMUNE INC(EVMN)1,926,9431,926,943044,30025,6098.32%-18,691
OCULIS HOLDING AG(OCS)1,680,2831,506,250-174,03344,67920,8926.79%-23,787
Page 1 of 1
Pivotal bioVenture Partners Investment Advisor LLC — 13F Holdings — Q2 2026 | TickerTrail